Article

Peroxiredoxin 5 regulates osteogenic differentiation via interaction with hnRNPK during…

medRxiv · 2022 · Cho, E.; Che, X.; Ang, M. J.; Cheon, S.; Lee, J.; Kim, K.; Lee, C. H.; Lee, S.-Y.; Yang, H.-Y.; Moon, C.; Park, C.; Choi, J.-Y.; Lee, T.-H.

Key facts

Title Peroxiredoxin 5 regulates osteogenic differentiation via interaction with hnRNPK during bone regeneration
First author Cho, E.; Che, X.; Ang, M. J.; Cheon, S.; Lee, J.; Kim, K.; Lee, C. H.; Lee, S.-Y.; Yang, H.-Y.; Moon, C.; Park, C.; Choi, J.-Y.; Lee, T.-H.
Journal medRxiv
Published Jun 10, 2022
DOI 10.1101/2022.06.09.495435
Devices mentioned K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967, K923274 and 10 more
Product codes mentioned EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, JCJ, JJH and 1 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature